TRUST AND RELIABILITY OF AI SYSTEMS IN EARLY CANCER DIAGNOSTICS: A NARRATIVE REVIEW
DOI:
https://doi.org/10.31435/ijitss.2(50).2026.5906Keywords:
Artificial Intelligence, Early Cancer Detection, Algorithmic Bias, Explainable AI, Clinical Validation, Regulatory OversightAbstract
Artificial intelligence (AI) tools are now embedded in many early cancer diagnostic workflows, with selected systems matching or surpassing human readers in mammography, low-dose computed tomography, colonoscopy, dermoscopy, and digital pathology. Whether such tools can be safely scaled depends on more than headline accuracy. Clinicians, patients, regulators, and health systems must be able to trust them and rely on their behaviour across diverse populations and over time. This narrative review draws together evidence from PubMed and PubMed Central published between 2018 and 2026, with priority given to randomised trials, large prospective studies, systematic reviews, and authoritative regulatory analyses. We examine six interrelated dimensions of trust and reliability: diagnostic performance against clinical reference standards; external validity and generalisability across populations, scanners, and time; algorithmic bias and health equity; transparency through explainable AI methods; human–AI interaction, including automation bias; and the evolving regulatory landscape under the United States Food and Drug Administration and the European Union AI Act. Recent evidence shows that well-validated AI can raise cancer detection rates and reduce reader workload in real-world screening. Reliability, however, is constrained by limited external validation, demographic under-representation, opaque decision-making, and uneven post-market surveillance. Trust in this domain is not an intrinsic property of any single model. It emerges from rigorous validation, transparent reporting, equitable performance, regulatory oversight, and meaningful human oversight maintained throughout the lifecycle of every deployed tool.
References
American Psychological Association. (2020). Publication manual of the American Psychological Association (7th ed.). https://doi.org/10.1037/0000165-000
Anderson, A. W., Marinovich, M. L., Houssami, N., Lowry, K. P., Elmore, J. G., Buist, D. S. M., Hofvind, S., & Lee, C. I. (2022). Independent external validation of artificial intelligence algorithms for automated interpretation of screening mammography: A systematic review. Journal of the American College of Radiology, 19(2), 259–273. https://doi.org/10.1016/j.jacr.2021.11.008
Baethge, C., Goldbeck-Wood, S., & Mertens, S. (2019). SANRA—a scale for the quality assessment of narrative review articles. Research Integrity and Peer Review, 4, Article 5. https://doi.org/10.1186/s41073-019-0064-8
Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R. L., Soerjomataram, I., & Jemal, A. (2024). Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 74(3), 229–263. https://doi.org/10.3322/caac.21834
Bulten, W., Kartasalo, K., Chen, P.-H. C., Ström, P., Pinckaers, H., Nagpal, K., Cai, Y., Steiner, D. F., van Boven, H., Vink, R., Hulsbergen-van de Kaa, C., van der Laak, J., Amin, M. B., Evans, A. J., van der Kwast, T., Allan, R., Humphrey, P. A., Grönberg, H., Samaratunga, H., ... Litjens, G. (2022). Artificial intelligence for diagnosis and Gleason grading of prostate cancer: The PANDA challenge. Nature Medicine, 28(1), 154–163. https://doi.org/10.1038/s41591-021-01620-2
Collins, G. S., Moons, K. G. M., Dhiman, P., Riley, R. D., Beam, A. L., Van Calster, B., Ghassemi, M., Liu, X., Reitsma, J. B., van Smeden, M., Boulesteix, A.-L., Camaradou, J. C., Celi, L. A., Denaxas, S., Denniston, A. K., Glocker, B., Golub, R. M., Harvey, H., Heinze, G., ... Logullo, P. (2024). TRIPOD+AI statement: Updated guidance for reporting clinical prediction models that use regression or machine learning methods. BMJ, 385, Article e078378. https://doi.org/10.1136/bmj-2023-078378
Cruz Rivera, S., Liu, X., Chan, A.-W., Denniston, A. K., & Calvert, M. J. (2020). Guidelines for clinical trial protocols for interventions involving artificial intelligence: The SPIRIT-AI extension. Nature Medicine, 26(9), 1351–1363. https://doi.org/10.1038/s41591-020-1037-7
Daneshjou, R., Vodrahalli, K., Novoa, R. A., Jenkins, M., Liang, W., Rotemberg, V., Ko, J., Swetter, S. M., Bailey, E. E., Gevaert, O., Mukherjee, P., Phung, M., Yekrang, K., Fong, B., Sahasrabudhe, R., Allerup, J. A. C., Okata-Karigane, U., Zou, J., & Chiou, A. S. (2022). Disparities in dermatology AI performance on a diverse, curated clinical image set. Science Advances, 8(32), Article eabq6147. https://doi.org/10.1126/sciadv.abq6147
Dratsch, T., Chen, X., Rezazade Mehrizi, M., Kloeckner, R., Mähringer-Kunz, A., Püsken, M., Baeßler, B., Sauer, S., Maintz, D., & Pinto Dos Santos, D. (2023). Automation bias in mammography: The impact of artificial intelligence BI-RADS suggestions on reader performance. Radiology, 307(4), Article e222176. https://doi.org/10.1148/radiol.222176
Drukker, K., Chen, W., Gichoya, J. W., Gruszauskas, N. P., Kalpathy-Cramer, J., Koyejo, S., Myers, K. J., Sá, R. C., Sahiner, B., Whitney, H., Zhang, Z., & Giger, M. L. (2023). Toward fairness in artificial intelligence for medical image analysis: Identification and mitigation of potential biases in the roadmap from data collection to model deployment. Journal of Medical Imaging, 10(6), Article 061104. https://doi.org/10.1117/1.JMI.10.6.061104
Esteva, A., Kuprel, B., Novoa, R. A., Ko, J., Swetter, S. M., Blau, H. M., & Thrun, S. (2017). Dermatologist-level classification of skin cancer with deep neural networks. Nature, 542(7639), 115–118. https://doi.org/10.1038/nature21056
Gastounioti, A., Eriksson, M., Cohen, E. A., Mankowski, W., Pantalone, L., Ehsan, S., McCarthy, A. M., Kontos, D., Hall, P., & Conant, E. F. (2022). External validation of a mammography-derived AI-based risk model in a U.S. breast cancer screening cohort of White and Black women. Cancers, 14(19), Article 4803. https://doi.org/10.3390/cancers14194803
Geppert, J., Asgharzadeh, A., Brown, A., Stinton, C., Helm, E. J., Jayakody, S., Todkill, D., Gallacher, D., Ghiasvand, H., Patel, M., Auguste, P., Tsertsvadze, A., Chen, Y.-F., Grove, A., Shinkins, B., Clarke, A., & Taylor-Phillips, S. (2024). Software using artificial intelligence for nodule and cancer detection in CT lung cancer screening: Systematic review of test accuracy studies. Thorax, 79(11), 1040–1049. https://doi.org/10.1136/thorax-2024-221662
Ghasemi, A., Hashtarkhani, S., Schwartz, D. L., & Shaban-Nejad, A. (2024). Explainable artificial intelligence in breast cancer detection and risk prediction: A systematic scoping review. Cancer Innovation, 3(5), Article e136. https://doi.org/10.1002/cai2.136
Hassan, M., Kushniruk, A., & Borycki, E. (2024). Barriers to and facilitators of artificial intelligence adoption in health care: Scoping review. JMIR Human Factors, 11, Article e48633. https://doi.org/10.2196/48633
Hernström, V., Josefsson, V., Sartor, H., Schmidt, D., Larsson, A.-M., Hofvind, S., Andersson, I., Rosso, A., Hagberg, O., & Lång, K. (2025). Screening performance and characteristics of breast cancer detected in the Mammography Screening with Artificial Intelligence trial (MASAI): A randomised, controlled, parallel-group, non-inferiority, single-blinded, screening accuracy study. The Lancet Digital Health, 7(3), e175–e183. https://doi.org/10.1016/S2589-7500(24)00267-X
Hosny, A., Parmar, C., Quackenbush, J., Schwartz, L. H., & Aerts, H. J. W. L. (2018). Artificial intelligence in radiology. Nature Reviews Cancer, 18(8), 500–510. https://doi.org/10.1038/s41568-018-0016-5
Joshi, G., Jain, A., Araveeti, S. R., Adhikari, S., Garg, H., & Bhandari, M. (2024). FDA-approved artificial intelligence and machine learning (AI/ML)-enabled medical devices: An updated landscape. Electronics, 13(3), Article 498. https://doi.org/10.3390/electronics13030498
Kromrey, M.-L., Steiner, L., Schön, F., Gamain, J., Roller, C., & Malsch, C. (2024). Navigating the spectrum: Assessing the concordance of ML-based AI findings with radiology in chest X-rays in clinical settings. Healthcare, 12(22), Article 2225. https://doi.org/10.3390/healthcare12222225
Lång, K., Josefsson, V., Larsson, A.-M., Larsson, S., Högberg, C., Sartor, H., Hofvind, S., Andersson, I., & Rosso, A. (2023). Artificial intelligence-supported screen reading versus standard double reading in the Mammography Screening with Artificial Intelligence trial (MASAI): A clinical safety analysis of a randomised, controlled, non-inferiority, single-blinded, screening accuracy study. The Lancet Oncology, 24(8), 936–944. https://doi.org/10.1016/S1470-2045(23)00298-X
Lauritzen, A. D., Rodríguez-Ruiz, A., von Euler-Chelpin, M. C., Lynge, E., Vejborg, I., Nielsen, M., Karssemeijer, N., & Lillholm, M. (2022). An artificial intelligence-based mammography screening protocol for breast cancer: Outcome and radiologist workload. Radiology, 304(1), 41–49. https://doi.org/10.1148/radiol.210948
Liu, X., Cruz Rivera, S., Moher, D., Calvert, M. J., & Denniston, A. K. (2020). Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: The CONSORT-AI extension. Nature Medicine, 26(9), 1364–1374. https://doi.org/10.1038/s41591-020-1034-x
Ng, A. Y., Oberije, C. J. G., Ambrózay, É., Szabó, E., Serfőző, O., Karpati, E., Fox, G., Glocker, B., Morris, E. A., Forrai, G., & Kecskemethy, P. D. (2023). Prospective implementation of AI-assisted screen reading to improve early detection of breast cancer. Nature Medicine, 29(12), 3044–3049. https://doi.org/10.1038/s41591-023-02625-9
Norori, N., Hu, Q., Aellen, F. M., Faraci, F. D., & Tzovara, A. (2021). Addressing bias in big data and AI for health care: A call for open science. Patterns, 2(10), Article 100347. https://doi.org/10.1016/j.patter.2021.100347
Park, S. H., & Suh, C. H. (2024). Reporting guidelines for artificial intelligence studies in healthcare (for both conventional and large language models): What’s new in 2024. Korean Journal of Radiology, 25(8), 687–690. https://doi.org/10.3348/kjr.2024.0598
Perincheri, S., Levi, A. W., Celli, R., Gershkovich, P., Rimm, D., Morrow, J. S., Rothrock, B., Raciti, P., Klimstra, D., & Sinard, J. (2021). An independent assessment of an artificial intelligence system for prostate cancer detection shows strong diagnostic accuracy. Modern Pathology, 34(8), 1588–1595. https://doi.org/10.1038/s41379-021-00794-x
Schurz, H., Solander, K., Åström, D., Cossío, F., Choi, T., Dustler, M., Lundström, C., Gustafsson, H., Zackrisson, S., & Strand, F. (2025). Simulating mismatch between calibration and target population in AI for mammography: The retrospective VAIB study. npj Digital Medicine, 8, Article 259. https://doi.org/10.1038/s41746-025-01623-0
Soleymanjahi, S., Huebner, J., Elmansy, L., Rajashekar, N., Lüdtke, N., Paracha, R., Thompson, R., Grimshaw, A. A., Foroutan, F., Sultan, S., & Shung, D. L. (2024). Artificial intelligence-assisted colonoscopy for polyp detection: A systematic review and meta-analysis. Annals of Internal Medicine, 177(12), 1652–1663. https://doi.org/10.7326/ANNALS-24-00981
Tschandl, P., Codella, N., Akay, B. N., Argenziano, G., Braun, R. P., Cabo, H., Gutman, D., Halpern, A., Helba, B., Hofmann-Wellenhof, R., Lallas, A., Lapins, J., Longo, C., Malvehy, J., Marchetti, M. A., Marghoob, A., Menzies, S., Oakley, A., Paoli, J., ... Kittler, H. (2019). Comparison of the accuracy of human readers versus machine-learning algorithms for pigmented skin lesion classification: An open, web-based, international, diagnostic study. The Lancet Oncology, 20(7), 938–947. https://doi.org/10.1016/S1470-2045(19)30333-X
United States Food and Drug Administration. (2024). Marketing submission recommendations for a predetermined change control plan for artificial intelligence-enabled device software functions: Guidance for industry and Food and Drug Administration staff. U.S. Department of Health and Human Services. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/marketing-submission-recommendations-predetermined-change-control-plan-artificial-intelligence
United States Food and Drug Administration. (2025). Artificial intelligence and machine learning (AI/ML)-enabled medical devices. U.S. Department of Health and Human Services. https://www.fda.gov/medical-devices/software-medical-device-samd/artificial-intelligence-and-machine-learning-aiml-enabled-medical-devices
van der Laak, J., Litjens, G., & Ciompi, F. (2021). Deep learning in histopathology: The path to the clinic. Nature Medicine, 27(5), 775–784. https://doi.org/10.1038/s41591-021-01343-4
van Kolfschooten, H., & van Oirschot, J. (2024). The EU Artificial Intelligence Act (2024): Implications for healthcare. Health Policy, 149, Article 105152. https://doi.org/10.1016/j.healthpol.2024.105152
Vardas, E. P., Marketou, M., & Vardas, P. E. (2025). Medicine, healthcare and the AI Act: Gaps, challenges and future implications. European Heart Journal—Digital Health, 6(4), 833–839. https://doi.org/10.1093/ehjdh/ztaf041
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Emil Pałyga, Mateusz Kwiatkowski, Zofia Leżańska, Katarzyna Marcinkowska, Aleksandra Cieślak, Sara Demkow, Karolina Siemińska, Joanna Sowińska, Natalia Paluszkiewicz, Sandra Bryg
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.
How to Cite
